MYO Myomo
- 3.5300
- +0.2600+7.95%
- 3.5300
- 0.00000.00%
Myomo News
Press Release: Myomo to Report First Quarter Financial Results on May 8, 2024
Myomo to Report First Quarter Financial Results on May 8, 2024 BOSTON--(BUSINESS WIRE)--May 01, 2024-- Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics compan
Myomo Appoints Heather Getz to Its Board of Directors
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO)
Myomo(MYO.US) Director Buys US$175K in Common Stocks
$Myomo(MYO.US)$ Director KIRK THOMAS F purchased 50,000 shares of Common Stocks on Mar 14, 2024 at an average price of $3.5 for a total value of $175K.Source: Announcement What is statement of changes
Myomo Inc.: Strong Growth and Regulatory Tailwinds Support Buy Rating
Myomo Has a Strong Outlook for 2024 With New Medicare Coverage
Earnings Call Summary | Myomo(MYO.US) Q4 2023 Earnings Conference
The following is a summary of the Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript:Financial Performance:Myomo achieved a successful growth in product revenues by 20% year-over-year, with a reductio
Myomo Sees Q1 2024 Revenue $4.1M-$4.3M Vs $4.523M Est.
Myomo Sees Q1 2024 Revenue $4.1M-$4.3M Vs $4.523M Est.
Recap: Myomo Q4 Earnings
Myomo (AMEX:MYO) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsMyomo missed estimated earnings by -17.0%, re
Myomo GAAP EPS of -$0.07 Misses by $0.01, Revenue of $4.76M Misses by $0.06M
Earnings Flash (MYO) MYOMO Reports Q4 Revenue $4.8M, Vs. Street Est of $4.8M
04:07 PM EST, 03/07/2024 (MT Newswires) -- Earnings Flash (MYO) MYOMO Reports Q4 Revenue $4.8M, vs. Street Est of $4.8M
Myomo 4Q Loss/Shr 7c >MYO
Myomo 4Q Loss/Shr 7c >MYO
Press Release: Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results Q4 total revenue of $4.8 million, up 18% over the prior year Addition of Medicare Part B patients to backlog results in record 183 M
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. • Stevanato Gr (NYSE:STVN) is likely to report quarte
Myomo Earnings Preview
Myomo (AMEX:MYO) is set to give its latest quarterly earnings report on Thursday, 2024-03-07. Here's what investors need to know before the announcement.Analysts estimate that Myomo will report an ear
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAdial Pharmaceuticals (NASDAQ:ADIL) stock increased by 58.8% to $3.24 during Friday's regular session. The market value of their outstanding shares is at $5.3 million. BioVie (NASDAQ:BIVI) stoc
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
Myomo Inc Updates Executive Financial Agreements
Myomo Completes $6 Million Share Offering
Myomo (MYO) said Friday it has closed its registered direct offering of nearly 1.6 million shares at $3.80 each to certain institutional investors and company insiders, raising about $6 million. The
Analysis
Price Target
No Data
